Intraocular Melanoma Unknown Status Phase 2 Trials for Tamoxifen (DB00675)

Also known as: Intraocular melanoma NOS

IndicationStatusPhase
DBCOND0028574 (Intraocular Melanoma)Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00489944Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular MelanomaTreatment